Clinical Trials Browser

Phase NA × Recruiting × Trastuzumab × Clear all

NCT06035679 2025-03-12

Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer

Phase NA Recruiting

Breast Cancer Female